コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 e used fumonisin B1, a specific inhibitor of ceramide synthase.
2 pathway by coordinate activation of SPT and ceramide synthase.
3 onisin B1, an inhibitor of the CoA-dependent ceramide synthase.
4 ovo synthesis coordinated through the enzyme ceramide synthase.
5 enerates the C-terminal peptide-epitope of a ceramide synthase.
6 onisin B1, an in vitro inhibitor of (dihydro)ceramide synthase.
8 ration of C18-ceramide via the expression of ceramide synthase 1 (CerS1), and not C16-ceramide by Cer
10 the sphingolipid enzyme inositol-phosphoryl ceramide synthase 1 (Ipc1) regulates melanin production
11 onymous mutation in CERS1, the gene encoding ceramide synthase 1, in 4 siblings affected by a progres
12 novo-generated C(18)- and C(16)-ceramides by ceramide synthases 1 and 6 (CerS1 and CerS6) play opposi
16 chain length in insulin signaling by using a ceramide synthase 2 (CerS2) null mouse, which is unable
18 ed that FTY720 is a competitive inhibitor of ceramide synthase 2 toward dihydrosphingosine with an ap
20 chanistically, Bcl2L13 binds to proapoptotic ceramide synthases 2 (CerS2) and 6 (CerS6) via a unique
21 ased levels of maternal transcripts encoding ceramide synthase 2b (Cers2b), and loss of Cers2b in sph
23 , 1-deoxysphinganine selectively upregulated ceramide synthase 5 expression and was converted to 1-de
24 and demonstrated a requirement for (dihydro)ceramide synthase 5 in cardiomyocyte autophagy and myris
26 specimens and cell lines and determined that ceramide synthase 6 (CERS6) is markedly overexpressed co
30 istant SW620 cells expressed lower levels of ceramide synthase 6 (CerS6, also known as longevity assu
31 use line harboring an enzymatically inactive ceramide synthase 6 (CerS6KO) gene and lacz reporter cDN
35 umonisin B1, a specific natural inhibitor of ceramide synthase, abrogated both ceramide production an
36 fferentially regulates functionally distinct ceramide synthase activities as part of a broader sphing
37 sulted in a rapid increase (within 5 min) in ceramide synthase activity (as measured by incorporation
38 tamin C, attributable, in part, to increased ceramide synthase activity (over 2-fold, p = 0.01); both
39 es, in contrast, displayed increased class I ceramide synthase activity but reduced class II ceramide
41 accumulation of ceramide via stimulation of ceramide synthase activity in mitochondria, and that JNK
43 TNFalpha-induced cell death, suggesting that ceramide synthase activity is crucial for the progressio
49 d (addition of fumonisin B1, an inhibitor of ceramide synthase) also reduced [3H]PDBu binding; theref
50 de generation by activation of mitochondrial ceramide synthase and de novo synthesis of ceramide.
51 ly, fumonisin B1, which selectively inhibits ceramide synthase and decreases de novo formation of cer
52 m cells was obliterated upon inactivation of ceramide synthase and restored upon microinjection of lo
55 first time the ability of FTY720 to inhibit ceramide synthases and modulate the intracellular balanc
56 IR triggers SIRT3-dependent deacetylation of ceramide synthases and the elevation of ceramide, which
57 ve useful to study the role of the different ceramide synthases and the resulting N-acyl (dihydro)cer
60 nd that de novo ceramide synthesis involving ceramide synthase appears to be responsible for heat-ind
62 crom), a specific inhibitor of CoA-dependent ceramide synthase, blocked 80% of the ceramide generated
63 inhibited by fumonisin B(1), an inhibitor of ceramide synthase, but not by ISP-1, an inhibitor of ser
64 ely blocked by fumonisin B1, an inhibitor of ceramide synthase, but only partially reduced by myrioci
65 at of fumonisin B1, a classical inhibitor of ceramide synthases, but differed in the efficiency to in
67 oid bases are also produced by inhibition of ceramide synthase by fumonisins, mycotoxins produced by
71 sed by a transiently increased expression of ceramide synthase (CerS) 6 in monocytes/macrophages and
72 SPTLC3 catalytic subunit, as well as reduced ceramide synthase (CerS) activity related to reduced exp
74 ted cell death, suggesting the presence of a ceramide synthase (CerS)-dependent, sphingosine-derived
77 in B(1) (FB(1)) is a mycotoxin that inhibits ceramide synthases (CerS) and causes kidney and liver to
78 Ceramides are synthesized by a family of six ceramide synthases (CerS) in mammals, which produce cera
79 sphingolipid metabolism, is generated by six ceramide synthases (CerS) that differ in substrate speci
80 sphingolipids, is synthesized by a family of ceramide synthases (CerS) that each use acyl-CoAs of def
81 ceramides are synthesized by a family of six ceramide synthases (CerS), transmembrane proteins locate
87 tosis, mediated via activation of the enzyme ceramide synthase (CS) and de novo synthesis of the sphi
88 alternate cell death mechanism, mediated via ceramide synthase (CS)-stimulated de novo synthesis of t
89 thase rather than sphingomyelinases and that ceramide synthase-dependent ceramide generation plays a
90 role of CerS6 in mitochondria revealed that ceramide synthase down-regulation is associated with dra
91 istent with these findings, mutations in the ceramide-synthase-encoding genes barA and lagA also caus
98 als, and mutants lacking one of these, HYL-1/ceramide synthase, have defects in synaptic transmission
99 could be attributed to increased activity of ceramide synthase (i.e., 1.7-fold increase 8 h after ult
102 ll mice, and SIRT3 directly deacetylates the ceramide synthases in a NAD(+)-dependent manner that inc
104 sis demonstrated that these modifications of ceramide synthase increased its specific activity and st
105 showed that SIRT3-mediated deacetylation of ceramide synthases increased enzyme activity and ceramid
106 was independent of de novo synthesis, since ceramide synthase inhibition (with fumonisin B1) had no
107 or cells with FAS siRNA in the presence of a ceramide synthase inhibitor abrogated the up-regulation
109 icles from virus producer cells treated with ceramide synthase inhibitor fumonisin B1 or glucosylcera
110 PP2A inhibitors fostriecin and okadaic acid, ceramide synthase inhibitor fumonisin B1, and ROS scaven
111 eath in 30% of cells) in the presence of the ceramide synthase inhibitor fumonisin B1, which inhibite
112 wever, addition of fumonisin B1, a selective ceramide synthase inhibitor, attenuated TNF-alpha/CHX-in
113 of this hypothesis, we find that the potent ceramide synthase inhibitor, australifungin, completely
116 the N-acyl-sphinganine dehydrogenase (e.g., ceramide synthase) inhibitor significantly attenuated ca
117 ate for both serine palmitoyltransferase and ceramide synthase, into C16-ceramide, whereas SphK1 decr
119 tion of dihydrosphingosine or sphingosine by ceramide synthase is inhibited by the fungal toxin fumon
120 with wild-type plants, indicating that LOH1 ceramide synthase is most strongly inhibited by FB1.
122 ed CerS6 and its product C16-ceramide as the ceramide synthase isoform essential for the regulation o
123 asia-mutated (ATM) kinase normally represses ceramide synthase, its derepression in Atm(-/-) mice inc
125 to the actions of acid sphingomyelinase and ceramide synthase LASS 5, demonstrating the action of th
127 ecognized crypt stem cell target, activating ceramide synthase-mediated apoptosis to initiate intesti
128 ssor p53)-mediated accumulation of EGL-1 and ceramide synthase-mediated generation of ceramide throug
129 h phenocopied the Atm(-/-) mouse, reordering ceramide synthase-mediated stem cell death to become the
131 Decreasing ceramide levels by inhibiting ceramide synthase or neutral sphingomyelinase 2 leads to
132 induced via IsoGb4, which indicated that the ceramide synthase pathway is likely to be involved in ap
134 rst evidence that H(2)O(2) is a regulator of ceramide synthase rather than sphingomyelinases and that
136 ulator of bioactive sphingolipid metabolism, ceramide synthase, required for the production of functi
137 y artery endothelial cells, FTY720 inhibited ceramide synthases, resulting in decreased cellular leve
138 monstrate that overexpression of Arabidopsis ceramide synthases results in strongly divergent physiol
139 se (SPT), or fumonisin B(1), an inhibitor of ceramide synthase, retarded ceramide formation in respon
140 f SPT as well as fumonisin inhibition of the ceramide synthases, suggesting that increased expression
141 eover, A. nidulans possesses a second likely ceramide synthase that is essential and also regulates h
142 how that BarA, a putative acyl-CoA-dependent ceramide synthase that is unique to filamentous fungi me
143 ound to have reduced activity of the class I ceramide synthase that uses C16 fatty acid acyl-coenzyme
144 ubstrates but increased activity of class II ceramide synthases that use very-long-chain fatty acyl-c
145 H1; At3g25540)- and LOH3 (At1g19260)-encoded ceramide synthases use very-long-chain fatty acyl-CoA an
146 LCB substrates, and LOH2 (At3g19260)-encoded ceramide synthase uses palmitoyl-CoA and dihydroxy LCB s
147 ndria because of activation of mitochondrial ceramide synthase via post-translational mechanisms.
149 nce of acylation of increased sphingosine by ceramide synthase, we used fumonisin B1, a specific inhi
150 equired for apoptosis, because inhibition of ceramide synthase with fumonisin B1 decreased apoptosis
153 psis thaliana) contains three genes encoding ceramide synthases with distinct substrate specificities
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。